TerryLynnWellsMD

Clinical Trials

• Cardiovascular Risk Reduction Study (Reduction in Recurrent Major CV Disease Events) Start of enrollment: 2011 Apr 11

  Completed

  Phase 3

• ODYSSEY Outcomes: Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab Start of enrollment: 2012 Oct 01

  Completed

  Phase 3

• Efficacy and Safety of Benralizumab in Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) With Exacerbation History Start of enrollment: 2014 Jun 25

  Completed

  Phase 3

• A 52-Week Parallel Group Safety Study of TD-4208 in Chronic Obstructive Pulmonary Disease (COPD) Start of enrollment: 2015 Sep 01

  Completed

  Phase 3

• A Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Period in Subjects With Moderate to Very Severe COPD (Sophos) Start of enrollment: 2016 Apr 29

  Completed

  Phase 3

• Efficacy and Safety of LCZ696 Compared to Valsartan on Cognitive Function in Patients With Chronic Heart Failure and Preserved Ejection Fraction Start of enrollment: 2016 Nov 23

  Completed

  Phase 3

• Join now to see all